CancerVAX Lands Byron Elton
Experienced business executive to help establish the Company as a significant force in the field…
Social Media
CancerVAX Lands Byron Elton
Experienced business executive to help establish the Company as a significant force in the field…
Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology
Results from three participants demonstrated no incidence of acute rejection at durations of 56, 154,…
Additional Detailed Analyses From Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD/PDâ„¢ 2023 Annual Meeting
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line Image: GreenLight Biosciences…
Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results
`Four patients enrolled in open-label Phase 1b kidney transplant trial with clinical data on first…
WSFS Bank Study Finds Americans Are Confident Managing Their Money, But Inflation, Rising Costs and Fears of an Economic Downturn Are Impacting Financial Security
WILMINGTON, Del.–(BUSINESS WIRE)–A new survey from WSFS Bank, the primary subsidiary of WSFS Financial Corporation…
Secret Deodorant Launches Initiative Empowering Women to Achieve Financial Wellness
Exclusive NYSE event kicks off multi-year program to advance economic equality so women don’t have…
New Data Presented at AD/PD™ 2023 Show Biogen’s BIIB080 (MAPT ASO) Substantially Reduced Tau Protein Levels in Patients with Early-stage Alzheimer’s Disease
The BIIB080 Phase 1b clinical study is the first to show a reduction of this…
New Data Presented at AD/PD™ 2023 Show Biogen’s BIIB080 (MAPT ASO) Substantially Reduced Tau Protein Levels in Patients with Early-stage Alzheimer’s Disease
The BIIB080 Phase 1b clinical study is the first to show a reduction of this…
Libtayo® (cemiplimab) in Combination with Chemotherapy Approved by European Commission for the First-line Treatment of Advanced PD-L1 Positive Non-small Cell Lung Cancer (NSCLC)
Libtayo-based combination demonstrated superior survival outcomes compared to chemotherapy alone in Phase 3 trial designed…
Libtayo® (cemiplimab) in Combination with Chemotherapy Approved by European Commission for the First-line Treatment of Advanced PD-L1 Positive Non-small Cell Lung Cancer (NSCLC)
Libtayo-based combination demonstrated superior survival outcomes compared to chemotherapy alone in Phase 3 trial designed…
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
GreenLight’s RTP greenhouse facility in North Carolina GreenLight’s RTP greenhouse facility in North Carolina Two…
Danimer Scientific Announces Fourth Quarter and Full Year 2022 Results
— Results In-Line with March 20 Preannouncement — — Issues FY23 Guidance with Expectation for…
Camunda Community to Gather at Global Two-Day Summit May 10-11
Premier developer conference connects Camunda users and developers live in Berlin and online worldwide BOSTON–(BUSINESS…
Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis
WILMETTE, Ill., March 27, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis
WILMETTE, Ill., March 27, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
Technica Communications Named Finalist by PR Daily Awards
Ragan’s annual awards recognize climate tech agency for widespread coverage for EV charging manufacturing company…
Dine Brands Global, Inc. Announces Intention to Refinance Its Class A-2-I Senior Secured Notes Through a Securitization
GLENDALE, Calif.–(BUSINESS WIRE)–Dine Brands Global, Inc. (NYSE: DIN) (“Dine Brands” or the “Corporation”), the parent…